Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March

Factbox-Companies in Alzheimer's race after US nod for Eisai/Biogen drug

Explainer-Who is eligible for the new FDA-approved Alzheimer's drug?

US FDA grants standard approval of Eisai/Biogen Alzheimer's drug